Donovanosis epidemiology and demographics

Revision as of 19:00, 30 November 2012 by Kalsang Dolma (talk | contribs)
Jump to navigation Jump to search

Donovanosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Classification

Differentiating Donovanosis from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Treatment

Medical Therapy

Prevention

Case Studies

Case #1

Donovanosis epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

slides

Images

American Roentgen Ray Society Images of Donovanosis epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Donovanosis epidemiology and demographics

CDC on Donovanosis epidemiology and demographics

Donovanosis epidemiology and demographics in the news

Blogs on Donovanosis epidemiology and demographics

Directions to Hospitals Treating Donovanosis

Risk calculators and risk factors for Donovanosis epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Kalsang Dolma, M.B.B.S.[2]

Overview

Epidemiology and Demographics

Donovanosis is endemic in tropical and developing areas, including India, Guyana, New Guinea, central Australia, and southern Africa.

Age

Most infections occur in people ages 20-40. The disease is rarely seen in children or the elderly.

Gender

Men are affected more than twice as often as women.

References


Template:WikiDoc Sources